WOLD OLSEN PER 4
4 · GILEAD SCIENCES INC · Filed Feb 10, 2020
Insider Transaction Report
Form 4
WOLD OLSEN PER
Director
Transactions
- Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2020-02-07−20,282→ 0 totalExercise: $20.64Exp: 2021-05-12→ Common Stock (20,282 underlying) - Exercise/Conversion
Common Stock
2020-02-06$19.63/sh+21,720$426,364→ 119,574 total - Sale
Common Stock
2020-02-06$68.12/sh−21,720$1,479,605→ 97,854 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2020-02-06−21,720→ 0 totalExercise: $19.63Exp: 2020-05-11→ Common Stock (21,720 underlying) - Sale
Common Stock
2020-02-07$69.00/sh−20,282$1,399,458→ 97,854 total - Exercise/Conversion
Common Stock
2020-02-07$20.64/sh+20,282$418,722→ 118,136 total
Footnotes (3)
- [F1]Sale prices reported for the transactions reported here range from $68.1000 to $68.1750. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F2]The options vested quarterly over the first year of service and were fully vested on May 11, 2011.
- [F3]The options vested quarterly over the first year of service and were fully vested on May 12, 2012.